Nelson Dusetti: The Institut Choiseul recognises Jean-Baptiste Jaussaud as one of the top 100 economic leaders of tomorrow
Nelson Dusetti shared a post by Jean-Baptiste Jaussaud, CEO Predicting Med, on LinkedIn, adding:
“It’s an honor to serve as CSO of Predicting Med alongside such inspiring leaders Philippe Veran, Jean-Baptiste Jaussaud and Jua Iovanna. This recognition by Institut Choiseul of our CEO, Jean-Baptiste Jaussaud as one of the top 100 economic leaders of tomorrow underscores the significance of our work in the fight against pancreatic cancer. With PancreasView, we are making strides in personalized medicine to offer hope to patients. I couldn’t be prouder of our team and the future we’re building together.”
Quoting Jean-Baptiste Jaussaud:
“In this Olympic year, I didn’t get any medals, but it was still a great reward! I am very honored to be included in the ranking of the Institut Choiseul of the 100 economic leaders of tomorrow in our beautiful SOUTH!
Very proud to highlight the work of Predicting Med founded with two exceptional scientists Juan Iovanna and Nelson Dusetti and an entrepreneur who is my model for whom I have as much friendship as admiration Philippe Veran, famous president that Predicting Med has the honor to share with one of the most beautiful medtech in France: Biotech Dental.
This is particularly important at a time when our prognosis and targeted therapy test in pancreatic cancers, pancreas view is in clinical trials and is growing every day based on its know-how in multiomic sequencing (thank you Pauline Moussard ) and AI (thanks to my friend Professor Olivier Oullier ).
If Predicting Med is intended to participate in the advent of predictive and personalized medicine with its vision resolutely turned towards the future, it is also because our company has its foundations firmly anchored in our beautiful ecosystem where there is no shortage of models.
Special thanks to Olivia VERAN KENCK for being such an extraordinary friend who shows me on a daily basis how entrepreneurship is a royal road to take care of the health of others.
Thank you to my friends Leonor Lopes Gil, Fabien Giausseran, Anaïs Prétot, Romain Simmarano, Kevin Polizzi so many Choiseul laureates whose success is a source of inspiration and whose friendship is a source of motivation. Thank you and congratulations Pascal Lorot bringing together so many talents!
Finally, thank you to my partner, my confidante, my friend, my daily support, my partner, and wife Coralie JAUSSAUD whom I am moved to share a place in this ranking;)
This award is another opportunity to thank the partners of Predicting Med.”
Nelson Dusetti is the scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023